SELENASE peroral sol 100 mcg/2ml 90 amp buv 2 ml

7680537700371 CH-53770 A12CE02 07.02.1.

Reimbursement limitations:

XIGDUOXR4

Pour le traitement des patients diabétiques de type 2, lorsque le régime alimentaire et une …

SELENASE peroral sol 100 mcg/2ml 90 amp buv 2 ml
SELENASE peroral sol 100 mcg/2ml 90 amp buv 2 ml
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
5377001
CPT
-
Packaging group
90 x 2 ml
Unit
Ampulle(n)
Composition
natrii selenis pentahydricus 166.5 µg corresp. selenium 50 µg, excipiens ad solutionem pro 1 ml.

Articles (1)

Selenase peroral, Trinklösung
Ampullen
90 x 2 ml
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
10/06/2026
Professional SmPC
Français
10/06/2026
Patient information leaflet
Allemand
09/06/2026
Patient information leaflet
Français
09/06/2026
Patient information leaflet
Italien
09/06/2026

Detailed composition

Substance Quantity Type Category
natrii selenis pentahydricus
166.5 UG Substance WIZUS
selenium
50.0 UG Substance Wirkstoff (Principe actif)

Authorization holder

Plavidente GmbH

3374 Wangenried

Authorization information

Swissmedic authorization number
53770
Drug name
Selenase peroral, Trinklösung
Galenic form
LSOR
ATC Code
A12CE02
Authorization status
Z
Dispensation category
B
First authorization
09/02/2001
Authorization expiration date
31/12/9999
IT number
07.02.1.
Domain
Human medicine
Field of application
Nachgewiesener Selenmangel

Packaging details

Description (FR)
SELENASE peroral sol 100 mcg/2ml 90 amp buv 2 ml
Description (DE)
SELENASE peroral Lös 100 mcg/2ml 90 Trinkamp 2 ml
Market launch
09/02/2001
Narcotic (BTM)
No

Other packaging sizes

SELENASE peroral sol 100 mcg/2ml 20 amp buv 2 ml
20 x 2 ml AMP
View
SELENASE peroral sol 500 mcg/10ml 10 fl 10 ml
10 x 10 ml AMP
View
Buy us a coffee Explore the data